Wall Street Jolted By Trump-Fed Fight | Bloomberg Businessweek Daily 1/12/2026

The news article discusses the market's reaction to the Department of Justice's (DOJ) subpoena of the Federal Reserve, as well as related commentary from industry experts. The article also covers discussions with the CEOs of Pfizer and Acadia Pharmaceuticals about their pharmaceutical products, and a conversation with Pretium Co-President Stephen Scherr and Bloomberg's Sridhar Natarajan about President Trump's proposed ban on corporate homebuying. The key points are: - The DOJ has subpoenaed the Federal Reserve, leading to market volatility - Experts from Bloomberg and Richard Bernstein Advisors provide analysis on the situation - Pfizer's CEO discusses the company's weight-loss drug outlook - Acadia Pharmaceuticals' CEO talks about the firm's neuroscience treatments, including for Alzheimer's - Pretium's Co-President and a Bloomberg reporter discuss President Trump's bid to ban corporate homebuying